Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358536 · ClinicalTrials.gov registry record
Classification of COVID-19 Infection in Posteroanterior Chest X-rays
A clinical trial, sponsored by Dascena.
- Completed
- Registry status
- 230
- Enrollment target
NCT04358536: Completed study, sponsored by Dascena.
NCT04358536 is a clinical trial that has completed, run by Dascena. The registered enrollment target is 230 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04358536 has completed, sponsored by Dascena.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
Study Summary
The objective of this study is to assess three configurations of two convolutional deep neural network architectures for the classification of COVID-19 PCX images.
Primary Outcome
Identification of COVID-19 infection from chest X-ray analysis
Interventions
- DEVICE CovX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-04-17 |
What the finished NCT04358536 record still lists
NCT04358536 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CovX is the first listed.
NCT04358536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04358536 about?
NCT04358536 is a clinical study titled "Classification of COVID-19 Infection in Posteroanterior Chest X-rays". The objective of this study is to assess three configurations of two convolutional deep neural network architectures for the classification of COVID-19 PCX images.
What is the current status of trial NCT04358536?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2020-04-01. Estimated completion is 2020-04-17.
What interventions are being tested in trial NCT04358536?
The interventions under investigation include: CovX (DEVICE).
Who is sponsoring clinical trial NCT04358536?
This trial is sponsored by Dascena, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI